U.S. flag

An official website of the United States government

NM_000069.3(CACNA1S):c.520C>T (p.Arg174Trp) AND Malignant hyperthermia of anesthesia

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
Jun 1, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV004017719.1

Allele description [Variation Report for NM_000069.3(CACNA1S):c.520C>T (p.Arg174Trp)]

NM_000069.3(CACNA1S):c.520C>T (p.Arg174Trp)

Gene:
CACNA1S:calcium voltage-gated channel subunit alpha1 S [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
1q32.1
Genomic location:
Preferred name:
NM_000069.3(CACNA1S):c.520C>T (p.Arg174Trp)
HGVS:
  • NC_000001.11:g.201091993G>A
  • NG_009816.2:g.25574C>T
  • NM_000069.3:c.520C>TMANE SELECT
  • NP_000060.2:p.Arg174Trp
  • NC_000001.10:g.201061121G>A
  • NG_009816.1:g.25574C>T
  • NM_000069.2:c.520C>T
Protein change:
R174W
Links:
PharmGKB: 1449563861PA164749136; PharmGKB: 1449563861PA449461; PharmGKB: 1449563861PA449845; PharmGKB: 1449563861PA450106; PharmGKB: 1449563861PA450434; PharmGKB: 1449563861PA451341; PharmGKB: 1449563861PA451522; dbSNP: rs772226819
NCBI 1000 Genomes Browser:
rs772226819
Molecular consequence:
  • NM_000069.3:c.520C>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Malignant hyperthermia of anesthesia
Synonyms:
Hyperthermia of anesthesia
Identifiers:
MONDO: MONDO:0018493; MedGen: C0024591

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV004848031Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
criteria provided, single submitter

(ACMG Guidelines, 2015)
Likely Pathogenic
(Jun 1, 2023)
germlineclinical testing

PubMed (4)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Impaired gating of an L-Type Ca(2+) channel carrying a mutation linked to malignant hyperthermia.

Bannister RA, Beam KG.

Biophys J. 2013 May 7;104(9):1917-22. doi: 10.1016/j.bpj.2013.03.035. Erratum in: Biophys J. 2015 May 5;108(9):2420.

PubMed [citation]
PMID:
23663834
PMCID:
PMC3647151

The role of CACNA1S in predisposition to malignant hyperthermia.

Carpenter D, Ringrose C, Leo V, Morris A, Robinson RL, Halsall PJ, Hopkins PM, Shaw MA.

BMC Med Genet. 2009 Oct 13;10:104. doi: 10.1186/1471-2350-10-104.

PubMed [citation]
PMID:
19825159
PMCID:
PMC2770053
See all PubMed Citations (4)

Details of each submission

From Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine, SCV004848031.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (4)

Description

proposed classification - variant undergoing re-assessment, contact laboratory

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: May 19, 2024